2.05CHF
190.69 MCHF
3.16 BCHF
22.47 M
About SARTORIUS
Sector
CEO
Joachim Kreuzburg
Headquarters
Goettingen
Website
Employees (FY)
14.61 K
Founded
1990
ISIN
DE0007165631
FIGI
BBG006TLVMF9
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SRT3 is 179.50 CHF — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange SARTORIUS stocks are traded under the ticker SRT3.
SARTORIUS is going to release the next earnings report on Jul 19, 2024. Keep track of upcoming events with our Earnings Calendar.
SRT3 stock is 0% volatile and has beta coefficient of 2.29. Check out the list of the most volatile stocks — is SARTORIUS there?
One year price forecast for SARTORIUS has a max estimate of 403.15 CHF and a min estimate of 233.15 CHF.
SRT3 earnings for the last quarter are 0.87 CHF per share, whereas the estimation was 0.86 CHF resulting in a 1.46% surprise. The estimated earnings for the next quarter are 1.07 CHF per share. See more details about SARTORIUS earnings.
SARTORIUS revenue for the last quarter amounts to 789.70 M CHF despite the estimated figure of 775.65 M CHF. In the next quarter revenue is expected to reach 839.08 M CHF.
Yes, you can track SARTORIUS financials in yearly and quarterly reports right on TradingView.
SRT3 net income for the last quarter is 35.72 M CHF, while the quarter before that showed 7.81 M CHF of net income which accounts for 357.64% change. Track more SARTORIUS financial stats to get the full picture.
Today SARTORIUS has the market capitalization of 18.54 B, it has increased by 0.53% over the last week.
Yes, SRT3 dividends are paid annually. The last dividend per share was 0.72 CHF. As of today, Dividend Yield (TTM)% is 0.52%. Tracking SARTORIUS dividends might help you take more informed decisions.
SARTORIUS dividend yield was 0.22% in 2023, and payout ratio reached 24.67%. The year before the numbers were 0.39% and 14.53% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, SRT3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SARTORIUS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 14.61 K employees. See our rating of the largest employees — is SARTORIUS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SARTORIUS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SARTORIUS stock shows the buy signal. See more of SARTORIUS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SARTORIUS future price: according to them, SRT3 price has a max estimate of 403.14 CHF and a min estimate of 233.14 CHF. Read a more detailed SARTORIUS forecast: see what analysts think of SARTORIUS and suggest that you do with its stocks.